Study of BGM0504 for people with type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests an investigational drug called BGM0504 in people with type 2 diabetes who are already taking metformin or metformin plus another diabetes medicine. It aims to see if the drug can help lower blood sugar levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 2 diabetes.
- You have been taking metformin (at least 1000 mg per day) or metformin plus another diabetes pill called sulfonylurea for at least 8 weeks.
- Your body mass index (BMI) is 23 or higher.
- Your weight has been stable (no more than a 5% change) for the last 3 months.
- Your latest HbA1c (average blood sugar) is between 7.5% and 11.0%.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational pill for people with type 2 diabetes whose blood sugar is not well controlled despite lifestyle changes or metformin. The pill may help improve blood sugar control and is taken by mouth.
This study tests a new medication called Bofanglutide (an injectable drug, similar to others in its class) to see if it can help control blood sugar in adults with type 2 diabetes. It may also help with weight management. Participants will continue taking their current diabetes medication (metformin).
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
This study tests a new medication called PG-102 against a placebo and an existing medication (semaglutide) to see how well it controls blood sugar in people with type 2 diabetes. It may offer a new treatment option that could help lower your blood sugar levels.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.